Shareholders in Heidelberg Pharma (ETR:HPHA) are in the red if they invested three years ago

By Yahoo! Finance | Sep 2, 2024 at 02:38 AM EST

Heidelberg Pharma AG's long-term shareholders have faced significant losses, with share prices dropping 62% in three years. Despite revenue growth of 24% annually, the stock has declined by 17%. Investors should consider the company's financial health before investing.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.